Gradual development of organ damage in the murine zymosan-induced multiple organ dysfunction syndrome

Shock

Volumn 8, Issue 4, 1997, Pages 261-267

  Jansen, Monique J J M ^a   Hendriks, Thijs ^a,b   Verhofstad, Albert A J ^a   Lange, Wil ^a   Geeraedts Jr , Leo M G ^a   Goris, R Jan A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Surgery ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ZYMOSAN;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE COURSE; DISEASE MODEL; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; MULTIPLE ORGAN FAILURE; ORGAN SIZE; PATHOLOGY; SURVIVAL RATE; TIME;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; MULTIPLE ORGAN FAILURE; ORGAN SIZE; SURVIVAL RATE; TIME FACTORS; ZYMOSAN;

EID: 0031252283     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199710000-00005     Document Type: Article

References (23)

1. Baue AE: Multiple organ failure, multiple organ dysfunction syndrome, and the systemic inflammatory response syndrome: Where do we stand? [Editorial Review]. Shock 2:385-397, 1994.
2. Members of the American College of Chest physicians/Society of Critical Care Medicine consensus conference committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992.
3. Allardyce DB: Incidence of necrotizing pancreatitis and factors related to mortality. Am J Surg 154:295-299, 1987.
4. Aikowa N, Shinozawa Y, Ishibiki K, et al: Clinical analysis of multiple organ failure in burned patients. Burns 13:103-109, 1987.
5. Faist E, Baue AE, Dittmer H, Hebere G: Multiple organ failure in polytrauma patients. J Trauma 23:775-787, 1983.
6. Livingston DH, Deitch EA: Multiple organ failure: A common problem in the surgical intensive care unit patients. Ann Med 27:13-20, 1995.
7. Goris RJA, Boekhorstte TPA, Nuytinck JKS, Gimbrere JSF: Multiple organ failure. Generalized autodestructive inflammation? Arch Surg 120:1109-1115, 1985.
8. Moore FA, Moore EE: Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin N Am 75:257-277, 1995.
9. Goris RJA, Boekholtz WK, van Bebber IPT, Nuytinck JKS, Schillings PH: Multiple organ failure and sepsis without bacteria: An experimental model. Arch Surg 121:897-901, 1986.
10. von Bebber IPT, Boekholtz WKF, Goris RJA, et al: Neutrophil function and lipid peroxidation in a rat model of multiple organ failure. J Surg Res 47:471-475, 1989.
11. Jansen MJJM, Vogels MTE, van der Meer JWM, Hendriks T, Goris RJA: Inflammatory cytokines in an animal model for MODS. Crit Care Med 24:1196-1202, 1996.
12. Jansen MJJM, Hendriks T, Tax WJM, van der Meer JWM, Goris RJA: Increasing cytotoxic activity and production of reactive oxygen and nitrogen intermediates by peritoneal macrophages during the development of multiple organ dysfunction syndrome in mice. Scand J Immunol 44:361-368, 1996.
13. Steinberg S, Flynn W, Kelley K, et al: Development of a bacteria-independent model of the multiple organ failure syndrome. Arch Surg 124:1390-1395, 1989.
14. Shayevitz JR, Miller C, Johnson KJ, Rodriquez JL: Multiple organ dysfunction syndrome: End organ and systemic inflammatory response in a mouse model of nonseptic origin. Shock 4:389-396, 1995.
15. Deitch AE, Kemper AC, Specian RD, Berg RD: A study of the relationships among survival, gut-origin sepsis, and bacterial translocation in a model of systemic inflammation. J Trauma 32:141-147, 1992.
16. Nieuwenhuijzen GA, Hasekl Y, Lu Q, et al: Macrophage elimination increases bacterial translocation and gut-origin septicemia but attenuates symptoms and mortality rate in a model of systemic inflammation. Ann Surg 218:791-799, 1993.
17. Roumen RMH, Goris RJA: Intestinal permeability and bacterial translocation: Their role in the development of MOF. In Vincent JL (ed): Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer-Verlag, 1993, pp 249-257.
18. Goris RJA, van Dalen R: Selective decontamination in the intensive care unit. Adv Trauma Crit Care 7:61-78, 1992.
19. Goris RJA, van Bebber IPT, Hendriks T: Role of bacterial translocation and selective gut decontamination in the development of multiple organ failure. In Schlag G, Redl H, Siegel JH, Traber DL (eds): Shock, Sepsis, and Organ Failure. Second Wiggers Bernard Conference. Berlin: Springer Verlag, 1990, pp 133-144.
20. Peitzman AB, Udekwu AO, Ochoa J, Smith S: Bacterial translocation in trauma patients. J Trauma 31:1083-1087, 1991.
21. Moore FA, Moore EE, Pogetti R, et al: Gut bacterial translocation via the portal vein: A clinical perspective with major torso trauma. J Trauma 31:629-638, 1991.
22. Mainous MR, Ertel W, Chaudry IH, Deitch EA: The gut: A cytokine-generating organ in systemic inflammation? Shock 4:193-199, 1995.
23. Roumen RMH, Hendriks T, van der Ven-Jongekrijg J, et al: Cytokine patterns in patients after major vascular surgery, hemorrhagic shock and severe blunt trauma: Relation with subsequent ARDS and MOF. Ann Surg 218:769-776, 1993.